Altius Direct Electrical Nerve Stimulation System
Neuros Medical, Inc. · Decision date Aug 26, 2024
What did the FDA approve?
FDA records P230020 as an original PMA application. The recorded decision is approval, dated Aug 26, 2024.
FDA approval order statement
Approval order for Altius Direct Electrical Nerve Stimulation System. This device is indicated as an aid in the management of chronic intractable phantom and residual lower limb post-amputation pain in adult amputees.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Neurology
- Decision date
- Aug 26, 2024
Regulatory record facts
- Identifier
- P230020
- Regulatory pathway
- Premarket approval application
- Applicant
- Neuros Medical, Inc.
- Product code
- SAZ
- Decision code
- APPR
- Decision date
- Aug 26, 2024
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: stimulator, nerve terminus, totally implanted for chronic intractable post-amputation pain of the lower limb.
- Applicant
- Neuros Medical, Inc.
- Product code
- SAZ
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P230020 received
Application receipt date recorded by FDA.
P230020 · FDA decision
APPR
P230020/S011 · Related supplement
Altius Direct Electrical Nerve Stimulation System
Timeline entries are records held by MedtechLedger for P230020. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230020
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Neuros Medical, Inc. | PMA supplement | Oct 16, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Neuros Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 26800 Aliso Viejo Pkwy., Suite 250, Aliso Viejo, CA, 92656
Sources and methodology
- Original FDA record: P230020
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records